女性口服避孕药安全性问题探析  

Security of Women Oral Contraceptive

作　　者：李玮[1] 吴建国[1] 张玲[1] 王福影[1] 

机构地区：[1]南京医科大学,江苏南京210029

出　　处：《医学与哲学（B）》2007年第2期47-48,62,共3页Medicine & Philosophy(B)

基　　金：国家自然科学基金资助项目;项目编号:30571606;江苏省科技厅资助项目;项目编号:BR2005012;南京市科技局资助项目;项目编号:200503040

摘　　要：当前,女性口服避孕药因其高效和可靠而备受青睐,成为最有力的节育措施之一,但其安全性问题也引起广泛的关注。国家食品药品监督管理局(SFDA)、国家人口与计划生育委员会以及国家卫生部三方应该协调管理并解决避孕药品安全性的有关问题,同时,育龄女性也应引起足够的重视,以保障自身的生殖健康和生活质量。Nowadays women oral contraceptive（OC） is popular for high performance, accessibility and convenience and it has become one of the best contraception methods. For the adverse drug reaction of OC always are found after large scale administration, we should attach much importance to its security. The State Food and Drug Administration（SFDA）, the State Population and Family Plan Association and the Ministry of Health should raise some suggestions to solve this problem in chorus. Meanwhile, women should pay close attention to their health for quality of life and generation health of women to safeguard the family happiness and society harmony.

关 键 词：口服避孕药 安全性 管理 

分 类 号：R169.41[医药卫生—公共卫生与预防医学]